NCT01249443 2020-07-29Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionAIDS Malignancy ConsortiumPhase 1 Terminated17 enrolled
NCT00132067 2019-07-23Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity CancerNational Cancer Institute (NCI)Phase 2 Completed60 enrolled
NCT00910000 2018-09-10Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian CancerDana-Farber Cancer InstitutePhase 1/2 Terminated15 enrolled 12 charts
NCT00976183 2017-04-10Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian CarcinomaGynecologic Oncology AssociatesPhase 1/2 Terminated18 enrolled 7 charts
NCT00045006 2013-05-30Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00772798 2008-10-15A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerHerlev HospitalPhase 2 Unknown70 enrolled